메뉴 건너뛰기




Volumn 27, Issue 2, 2007, Pages 191-196

Hepatitis C in chronic kidney disease: Predialysis patients present more severe histological liver injury than hemodialysis patients?

Author keywords

Alanine aminotransferase; Chronic kidney disease; Fibrosis; Hemodialysis; Hepatitis C virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

EID: 34247161323     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100892     Document Type: Article
Times cited : (12)

References (39)
  • 1
    • 2442612829 scopus 로고    scopus 로고
    • Chronic hepatitis virus infections in patients on renal replacement therapy
    • Fehr T, Ambuhl PM: Chronic hepatitis virus infections in patients on renal replacement therapy. Nephrol Dial Transplant 2004; 19: 1049-1053.
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 1049-1053
    • Fehr, T.1    Ambuhl, P.M.2
  • 2
    • 0031754266 scopus 로고    scopus 로고
    • Risk of death among chronic dialysis patients infected with hepatitis C virus
    • Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629-634.
    • (1998) Am J Kidney Dis , vol.32 , pp. 629-634
    • Stehman-Breen, C.O.1    Emerson, S.2    Gretch, D.3    Johnson, R.J.4
  • 3
    • 0033770522 scopus 로고    scopus 로고
    • Prognosis of anti-hepatitis C virus antibodypositive patients on regular hemodialysis therapy
    • Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibodypositive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896-1902.
    • (2000) J Am Soc Nephrol , vol.11 , pp. 1896-1902
    • Nakayama, E.1    Akiba, T.2    Marumo, F.3    Sato, C.4
  • 4
  • 6
    • 0028363853 scopus 로고
    • Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: Prevalence, risk factors and relationship to liver disease
    • Fabrizi F, Marcelli D, Bacchini G, Guarnori I, Erba G, Locatelli F: Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Nephrol Dial Transplant 1994; 9: 780-784.
    • (1994) Nephrol Dial Transplant , vol.9 , pp. 780-784
    • Fabrizi, F.1    Marcelli, D.2    Bacchini, G.3    Guarnori, I.4    Erba, G.5    Locatelli, F.6
  • 8
    • 0028376877 scopus 로고
    • Hepatitis-C virus antibodies (anti HCV) in haemodialyzed vs. non-dialyzed patients
    • Kumar H, Naqvi SA, Ahmed A, Hamid S: Hepatitis-C virus antibodies (anti HCV) in haemodialyzed vs. non-dialyzed patients. J Pak Med Assoc 1994; 44: 28-30.
    • (1994) J Pak Med Assoc , vol.44 , pp. 28-30
    • Kumar, H.1    Naqvi, S.A.2    Ahmed, A.3    Hamid, S.4
  • 10
    • 0034749768 scopus 로고    scopus 로고
    • Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis
    • Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F: Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis 2001; 38: 1009-1015.
    • (2001) Am J Kidney Dis , vol.38 , pp. 1009-1015
    • Fabrizi, F.1    Lunghi, G.2    Finazzi, S.3    Colucci, P.4    Pagano, A.5    Ponticelli, C.6    Locatelli, F.7
  • 12
    • 12144288521 scopus 로고    scopus 로고
    • Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: Causes and consequences
    • Espinosa M, Martn-Malo A, Ojeda R, Santamara R, Soriano S, Aguera M, Aljama P: Marked reduction in the prevalence of hepatitis C virus infection in hemodialysis patients: causes and consequences. Am J Kidney Dis 2004; 43: 685-689.
    • (2004) Am J Kidney Dis , vol.43 , pp. 685-689
    • Espinosa, M.1    Martn-Malo, A.2    Ojeda, R.3    Santamara, R.4    Soriano, S.5    Aguera, M.6    Aljama, P.7
  • 14
    • 0014966294 scopus 로고
    • Alterations in serum enzymes in chronic renal failure
    • Bailey GL, Katz AI, Hampers CL, Merrill JP: Alterations in serum enzymes in chronic renal failure. JAMA 1970; 213: 2263-2265.
    • (1970) JAMA , vol.213 , pp. 2263-2265
    • Bailey, G.L.1    Katz, A.I.2    Hampers, C.L.3    Merrill, J.P.4
  • 17
    • 0033900359 scopus 로고    scopus 로고
    • High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied
    • Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P: High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000; 54: 151-156.
    • (2000) Clin Nephrol , vol.54 , pp. 151-156
    • Espinosa, M.1    Martin-Malo, A.2    Alvarez de Lara, M.A.3    Soriano, S.4    Aljama, P.5
  • 21
    • 0025035721 scopus 로고
    • Interference of heparin with the polymerase chain reaction
    • Beutler E, Gelbart T, Kuhl W: Interference of heparin with the polymerase chain reaction. Biotechniques 1990; 9: 166.
    • (1990) Biotechniques , vol.9 , pp. 166
    • Beutler, E.1    Gelbart, T.2    Kuhl, W.3
  • 22
    • 0032920578 scopus 로고    scopus 로고
    • Effects of heparin on polymerase chain reaction for blood white cells
    • Yokota M, Tatsumi N, Nathalang O, Yamada T, Tsuda I: Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal 1999; 13: 133-140.
    • (1999) J Clin Lab Anal , vol.13 , pp. 133-140
    • Yokota, M.1    Tatsumi, N.2    Nathalang, O.3    Yamada, T.4    Tsuda, I.5
  • 23
    • 0026558702 scopus 로고
    • Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus
    • Wang T, Wang TH, Shen JC, Lin SM, Chen DS: Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Chem Microbiol 1992; 30: 750-753.
    • (1992) J Chem Microbiol , vol.30 , pp. 750-753
    • Wang, T.1    Wang, T.H.2    Shen, J.C.3    Lin, S.M.4    Chen, D.S.5
  • 25
    • 0031854663 scopus 로고    scopus 로고
    • Prospective virological follow-up of hepatitis C infection in a haemodialysis unit
    • Halfon P, Khiri H, Feryn JM, Sayada C, Chanas M, Ouzan D: Prospective virological follow-up of hepatitis C infection in a haemodialysis unit. J Viral Hepatol 1998; 5: 115-121.
    • (1998) J Viral Hepatol , vol.5 , pp. 115-121
    • Halfon, P.1    Khiri, H.2    Feryn, J.M.3    Sayada, C.4    Chanas, M.5    Ouzan, D.6
  • 26
    • 0033974410 scopus 로고    scopus 로고
    • Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection
    • Furusyo N, Hayashi J, Ariyama I, Sawayama Y, Etoh Y, Shigematsu M, Kashiwagi S: Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 2000; 95: 490-496.
    • (2000) Am J Gastroenterol , vol.95 , pp. 490-496
    • Furusyo, N.1    Hayashi, J.2    Ariyama, I.3    Sawayama, Y.4    Etoh, Y.5    Shigematsu, M.6    Kashiwagi, S.7
  • 27
    • 1642476682 scopus 로고    scopus 로고
    • Kinetics of hepatitis C virus load during hemodialysis: Novel perspectives
    • Fabrizi F, Bunnapradist S, Lunghi G, Martin P: Kinetics of hepatitis C virus load during hemodialysis: novel perspectives. J Nephrol 2003; 16: 467-475.
    • (2003) J Nephrol , vol.16 , pp. 467-475
    • Fabrizi, F.1    Bunnapradist, S.2    Lunghi, G.3    Martin, P.4
  • 29
    • 0032787332 scopus 로고    scopus 로고
    • Chronic hepatitis C infection in patients with end stage renal disease: Characterization of liver histology and viral load in patients awaiting renal transplantation
    • Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML: Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 3576-3582.
    • (1999) Am J Gastroenterol , vol.94 , pp. 3576-3582
    • Sterling, R.K.1    Sanyal, A.J.2    Luketic, V.A.3    Stravitz, R.T.4    King, A.L.5    Post, A.B.6    Mills, A.S.7    Contos, M.J.8    Shiffman, M.L.9
  • 32
    • 0032538246 scopus 로고    scopus 로고
    • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention
    • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47: 1-39.
    • (1998) MMWR Recomm Rep , vol.47 , pp. 1-39
  • 33
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
    • K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
  • 34
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 35
    • 0027194352 scopus 로고
    • The nomenclature of chronic active hepatitis: An obituary
    • Ludwig J: The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274-278.
    • (1993) Gastroenterology , vol.105 , pp. 274-278
    • Ludwig, J.1
  • 36
    • 0030933395 scopus 로고    scopus 로고
    • Natural history of liver fibrosis progression in patients with chronic hepatitis C: The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
    • Poynard T, Bedossa P, Opolon P: Natural history of liver fibrosis progression in patients with chronic hepatitis C: the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832.
    • (1997) Lancet , vol.349 , pp. 825-832
    • Poynard, T.1    Bedossa, P.2    Opolon, P.3
  • 38
    • 0035009810 scopus 로고    scopus 로고
    • Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
    • Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J: Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol 2001; 34: 730-739.
    • (2001) J Hepatol , vol.34 , pp. 730-739
    • Poynard, T.1    Ratziu, V.2    Charlotte, F.3    Goodman, Z.4    McHutchison, J.5    Albrecht, J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.